FOLD – Amicus Therapeutics, Inc.
FOLD — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.53
Margin Of Safety %
-19
Put/Call OI Ratio
0.66
EPS Next Q Diff
0.14
EPS Last/This Y
0.74
EPS This/Next Y
0.27
Price
14.41
Target Price
14.5
Analyst Recom
3
Performance Q
1.12
Upside
-121.9%
Beta
0.48
Ticker: FOLD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | FOLD | 14.35 | 0.69 | 1.00 | 16367 |
| 2026-03-02 | FOLD | 14.36 | 0.69 | 9.79 | 16371 |
| 2026-03-03 | FOLD | 14.35 | 0.76 | 0.37 | 17196 |
| 2026-03-04 | FOLD | 14.34 | 0.76 | 0.00 | 17232 |
| 2026-03-05 | FOLD | 14.34 | 0.73 | 1.42 | 17643 |
| 2026-03-06 | FOLD | 14.34 | 0.73 | 0.50 | 17686 |
| 2026-03-09 | FOLD | 14.36 | 0.73 | 1.48 | 17656 |
| 2026-03-10 | FOLD | 14.35 | 0.73 | 62.20 | 17762 |
| 2026-03-11 | FOLD | 14.38 | 0.70 | 0.00 | 17456 |
| 2026-03-12 | FOLD | 14.37 | 0.70 | 0.00 | 17488 |
| 2026-03-13 | FOLD | 14.37 | 0.70 | 0.00 | 17488 |
| 2026-03-17 | FOLD | 14.37 | 0.69 | 999.99 | 17623 |
| 2026-03-18 | FOLD | 14.38 | 0.69 | 0.00 | 17627 |
| 2026-03-19 | FOLD | 14.38 | 0.69 | 999.99 | 17670 |
| 2026-03-20 | FOLD | 14.4 | 0.69 | 0.00 | 17681 |
| 2026-03-23 | FOLD | 14.41 | 0.65 | 1.02 | 16986 |
| 2026-03-24 | FOLD | 14.41 | 0.66 | 1.43 | 17052 |
| 2026-03-25 | FOLD | 14.43 | 0.67 | 0.47 | 17216 |
| 2026-03-26 | FOLD | 14.43 | 0.67 | 0.00 | 17298 |
| 2026-03-27 | FOLD | 14.41 | 0.66 | 0.67 | 17348 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | FOLD | 14.36 | 210.1 | 318.0 | 0.65 |
| 2026-03-02 | FOLD | 14.37 | 210.1 | 318.1 | 0.65 |
| 2026-03-03 | FOLD | 14.35 | 210.1 | 165.1 | 0.65 |
| 2026-03-04 | FOLD | 14.34 | 210.1 | 164.9 | 0.65 |
| 2026-03-05 | FOLD | 14.33 | 210.1 | 164.9 | 0.65 |
| 2026-03-06 | FOLD | 14.34 | 210.1 | 165.0 | 0.65 |
| 2026-03-09 | FOLD | 14.36 | 210.1 | 165.3 | 0.65 |
| 2026-03-10 | FOLD | 14.36 | 210.1 | 165.2 | 0.65 |
| 2026-03-11 | FOLD | 14.38 | 210.1 | 165.5 | 0.65 |
| 2026-03-12 | FOLD | 14.37 | 210.1 | 165.5 | 0.65 |
| 2026-03-13 | FOLD | 14.38 | 210.1 | 165.5 | 0.65 |
| 2026-03-17 | FOLD | 14.37 | 210.1 | 165.6 | 0.65 |
| 2026-03-18 | FOLD | 14.37 | 210.1 | 165.5 | 0.65 |
| 2026-03-19 | FOLD | 14.38 | 210.1 | 165.4 | 0.65 |
| 2026-03-20 | FOLD | 14.41 | 210.1 | 166.0 | 0.65 |
| 2026-03-23 | FOLD | 14.41 | 210.1 | 166.1 | 0.65 |
| 2026-03-24 | FOLD | 14.41 | 210.1 | 166.0 | 0.65 |
| 2026-03-25 | FOLD | 14.42 | 210.1 | 166.1 | 0.65 |
| 2026-03-26 | FOLD | 14.43 | 210.1 | 166.2 | 0.65 |
| 2026-03-27 | FOLD | 14.41 | 210.1 | 166.1 | 0.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | FOLD | -8.89 | 2.10 | 5.70 |
| 2026-03-02 | FOLD | -8.89 | 2.40 | 5.70 |
| 2026-03-03 | FOLD | -8.89 | 2.40 | 5.70 |
| 2026-03-04 | FOLD | -8.89 | 2.40 | 5.70 |
| 2026-03-05 | FOLD | -9.29 | 2.40 | 5.70 |
| 2026-03-06 | FOLD | -9.29 | 2.40 | 5.70 |
| 2026-03-09 | FOLD | -9.29 | 2.43 | 5.70 |
| 2026-03-10 | FOLD | -9.29 | 2.43 | 5.70 |
| 2026-03-11 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-12 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-13 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-17 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-18 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-19 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-20 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-23 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-24 | FOLD | -9.29 | 2.43 | 6.14 |
| 2026-03-25 | FOLD | -9.29 | 2.43 | 6.53 |
| 2026-03-26 | FOLD | -9.29 | 2.43 | 6.53 |
| 2026-03-27 | FOLD | -9.29 | 2.43 | 6.53 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.01
Avg. EPS Est. Current Quarter
0.09
Avg. EPS Est. Next Quarter
0.15
Insider Transactions
-9.29
Institutional Transactions
2.43
Beta
0.48
Average Sales Estimate Current Quarter
165
Average Sales Estimate Next Quarter
182
Fair Value
11.73
Quality Score
55
Growth Score
71
Sentiment Score
86
Actual DrawDown %
1.1
Max Drawdown 5-Year %
-61.2
Target Price
14.5
P/E
Forward P/E
23.86
PEG
P/S
7.13
P/B
16.33
P/Free Cash Flow
151.58
EPS
-0.09
Average EPS Est. Cur. Y
0.65
EPS Next Y. (Est.)
0.92
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-4.27
Relative Volume
0.34
Return on Equity vs Sector %
-37.2
Return on Equity vs Industry %
-21
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
166.1
◆
FOLD
Healthcare
$14.41
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
66.4
Range 1M
86.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
436.5%
EPS NY
99.4%
52W%
99.8%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+56.3% upside
Upside
+56.3%
Quality
55
MoS
-19%
Amicus Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 511
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally. The company's commercial product and product candidates consist of Galafold, an orally administered monotherapy for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; Pombiliti + Opfolda, a novel two-component treatment program for adults living with late-onset Pompe disease; and DMX-200, a small molecule inhibitor of the chemokine receptor 2 that is in a pivotal Phase 3 study for the treatment of focal segmental glomerulosclerosis (FSGS) kidney disease. It has collaboration and license agreement with GlaxoSmithKline to develop and commercialize Galafold; and Dimerix Limited for the commercialization of DMX-200 for the treatment of FSGS and other indications. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
FOLD
Latest News
—
Caricamento notizie per FOLD…
stock quote shares FOLD – Amicus Therapeutics, Inc. Stock Price stock today
news today FOLD – Amicus Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FOLD – Amicus Therapeutics, Inc. yahoo finance google finance
stock history FOLD – Amicus Therapeutics, Inc. invest stock market
stock prices FOLD premarket after hours
ticker FOLD fair value insiders trading